Natera (NTRA) Revenue & Revenue Breakdown
Natera Revenue Highlights
Latest Revenue (Y)
$1.70B
Latest Revenue (Q)
$439.76M
Main Segment (Y)
Product
Main Geography (Y)
United States
Natera Revenue by Period
Natera Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $1.70B | 56.75% |
2023-12-31 | $1.08B | 31.99% |
2022-12-31 | $820.22M | 31.13% |
2021-12-31 | $625.49M | 59.97% |
2020-12-31 | $391.00M | 29.33% |
2019-12-31 | $302.33M | 17.34% |
2018-12-31 | $257.65M | 22.15% |
2017-12-31 | $210.94M | -2.83% |
2016-12-31 | $217.07M | 14.04% |
2015-12-31 | $190.35M | 19.50% |
2014-12-31 | $159.29M | 188.72% |
2013-12-31 | $55.17M | 287.16% |
2012-12-31 | $14.25M | - |
Natera generated $1.70B in revenue during NA 2024, up 56.75% compared to the previous quarter, and up 561.28% compared to the same period a year ago.
Natera Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $439.76M | 6.39% |
2024-06-30 | $413.35M | 12.40% |
2024-03-31 | $367.74M | 18.20% |
2023-12-31 | $311.11M | 15.95% |
2023-09-30 | $268.31M | 2.64% |
2023-06-30 | $261.40M | 8.13% |
2023-03-31 | $241.76M | 11.28% |
2022-12-31 | $217.25M | 3.14% |
2022-09-30 | $210.64M | 6.27% |
2022-06-30 | $198.20M | 2.09% |
2022-03-31 | $194.13M | 12.20% |
2021-12-31 | $173.03M | 9.43% |
2021-09-30 | $158.12M | 11.33% |
2021-06-30 | $142.03M | -6.76% |
2021-03-31 | $152.32M | 35.54% |
2020-12-31 | $112.38M | 14.50% |
2020-09-30 | $98.14M | 13.50% |
2020-06-30 | $86.47M | -8.02% |
2020-03-31 | $94.01M | 12.94% |
2019-12-31 | $83.24M | 6.84% |
2019-09-30 | $77.91M | 4.78% |
2019-06-30 | $74.36M | 11.27% |
2019-03-31 | $66.82M | -0.21% |
2018-12-31 | $66.97M | 2.58% |
2018-09-30 | $65.28M | 3.51% |
2018-06-30 | $63.07M | 1.17% |
2018-03-31 | $62.34M | 15.95% |
2017-12-31 | $53.77M | -5.10% |
2017-09-30 | $56.66M | 5.67% |
2017-06-30 | $53.62M | 14.32% |
2017-03-31 | $46.90M | -4.86% |
2016-12-31 | $49.30M | -8.52% |
2016-09-30 | $53.89M | 3.66% |
2016-06-30 | $51.98M | -16.02% |
2016-03-31 | $61.90M | 16.99% |
2015-12-31 | $52.91M | 17.79% |
2015-09-30 | $44.92M | -0.37% |
2015-06-30 | $45.09M | -4.95% |
2015-03-31 | $47.44M | -4.91% |
2014-12-31 | $49.88M | 7.80% |
2014-09-30 | $46.27M | 29.13% |
2014-06-30 | $35.84M | 31.29% |
2014-03-31 | $27.30M | - |
Natera generated $439.76M in revenue during Q3 2024, up 6.39% compared to the previous quarter, and up 168.23% compared to the same period a year ago.
Natera Revenue Breakdown
Natera Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|---|
Licensing and other | $11.84M | $14.05M | $22.91M | $58.34M | - |
Product | $1.69B | $1.07B | $797.31M | $567.15M | $367.21M |
Oncology products | - | $19.30M | - | - | - |
Genetic testing services | - | $18.30M | - | - | - |
Licensing And Other | - | - | - | - | $23.79M |
Natera's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (99.30%), and Licensing and other (0.70%).
Quarterly Revenue by Product
Product/Service | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Licensing and other | $5.14M | $3.63M | $3.07M | $6.94M | $3.15M | $3.96M | $4.36M | $10.81M | $3.62M | $4.13M | $12.14M | - | - | - | - | - | - | - | - | - |
Product | $884.27M | $436.13M | $364.67M | $572.47M | $258.26M | $237.80M | $212.89M | $199.83M | $194.58M | $190.00M | $160.88M | $150.65M | $137.23M | $118.38M | $106.47M | $93.29M | $80.41M | $87.05M | $74.48M | $66.94M |
Oncology products | - | - | - | - | $19.30M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Royalty | - | - | - | - | $20.00M | $600.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Licensing And Other | - | - | - | - | - | - | - | - | - | - | - | $7.46M | $4.79M | $33.93M | $5.91M | $4.86M | $6.06M | $6.97M | $8.76M | $10.97M |
Other Licensing And Other Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $10.00M | - | - | - | - | - | - |
Other Licensing And Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $797.00K | $3.72M | $2.88M |
License And Development Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.80M | - | - |
Upfront License And Constellation And Paternity Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.37M | - | - |
Constellation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.25M |
Bgi Genomics Co Ltd | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $6.84M |
Hcs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $26.15M |
Other Genetic Tests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.23M |
Panorama Nipt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $37.56M |
Qiagen | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Natera's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (99.42%), and Licensing and other (0.58%).
Natera Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|---|
United States | $1.66B | $1.05B | $785.85M | $590.87M | - |
Americas, excluding U.S. | $6.62M | $4.91M | $3.71M | $4.05M | - |
Asia Pacific and Other | $8.66M | $7.22M | $14.03M | $10.14M | - |
Europe, Middle East, India, and Africa | $23.88M | $22.81M | $16.64M | $20.43M | - |
Europe Middle East India And Africa | - | - | - | - | $14.33M |
Americas Excluding Us | - | - | - | - | $3.47M |
U | - | - | - | - | $365.66M |
Other Geographic Areas | - | - | - | - | $7.54M |
Natera's latest annual revenue breakdown by geography, as of Dec 24: United States (97.69%), Europe, Middle East, India, and Africa (1.41%), Asia Pacific and Other (0.51%), and Americas, excluding U.S. (0.39%).
Quarterly Revenue by Country
Country | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States | $872.06M | $426.27M | $359.41M | $561.09M | $253.30M | $233.25M | $209.68M | $197.07M | $191.89M | $187.22M | $163.07M | - | - | - | - | - | - | - | - | - |
Americas, excluding U.S. | $3.14M | $2.00M | $1.48M | $2.54M | $1.21M | $1.16M | $1.28M | $1.16M | $530.00K | $741.00K | $995.00K | - | - | - | - | - | - | - | - | - |
Asia Pacific and Other | $3.23M | $3.76M | $1.67M | $3.79M | $1.28M | $2.15M | $2.04M | $7.46M | $2.05M | $2.48M | $2.86M | - | - | - | - | - | - | - | - | - |
Europe, Middle East, India, Africa | - | $7.72M | $5.18M | $5.62M | $5.20M | $4.96M | $3.74M | $3.69M | - | - | - | - | - | - | - | - | - | - | - | - |
E M E A | - | - | - | - | - | - | - | - | - | - | - | $5.60M | $4.26M | $4.46M | $3.52M | $3.58M | $3.48M | $3.50M | - | - |
Other Geographic Areas | - | - | - | - | - | - | - | - | - | - | - | $3.24M | $1.96M | $2.09M | $3.08M | $27.00K | $1.41M | $3.02M | $5.47M | $8.77M |
U | - | - | - | - | - | - | - | - | - | - | - | $148.03M | $134.81M | $144.96M | $104.66M | $93.51M | $80.76M | $86.73M | $73.33M | $64.84M |
Americas Excluding Us | - | - | - | - | - | - | - | - | - | - | - | $1.25M | $992.00K | $813.00K | $885.00K | $1.08M | $721.00K | $782.00K | $827.00K | $806.00K |
Natera's latest quarterly revenue breakdown by geography, as of Dec 24: United States (99.27%), Asia Pacific and Other (0.37%), and Americas, excluding U.S. (0.36%).
Natera Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ILMN | Illumina | $4.37B | $1.08B |
EXAS | Exact Sciences | $2.76B | $708.65M |
QGEN | Qiagen | $1.97B | $458.80M |
NTRA | Natera | $1.70B | $439.76M |
NEOG | Neogen | $924.22M | $220.98M |
GH | Guardant Health | $739.02M | $177.24M |
NEO | NeoGenomics | $660.57M | $167.82M |
CDNA | CareDx | $333.79M | $82.88M |
CSTL | Castle Biosciences | $332.07M | $85.78M |
TWST | Twist Bioscience | $312.97M | - |
DRIO | DarioHealth | $27.04M | $6.25M |
SERA | Sera Prognostics | $77.00K | $24.00K |
PSNL | Personalis | - | $22.58M |